VBI Vaccines Inc/BC Debt Conversion, Converted Instrument, Amount
VBI Vaccines Inc/BC reported Debt Conversion, Converted Instrument, Amount of $2.00 million for the 12-month period ending 2021-12-31, per its 10-K filed 2023-03-13.
Discontinued › Cash Flow › Financing Activities
us-gaap:DebtConversionConvertedInstrumentAmount1 · last filed 2023-03-13
- VBI Vaccines Inc/BC debt conversion, converted instrument, amount for the quarter ending 2021-12-31 was $0.00.
- VBI Vaccines Inc/BC debt conversion, converted instrument, amount for the quarter ending 2021-09-30 was $0.00.
- VBI Vaccines Inc/BC debt conversion, converted instrument, amount for the quarter ending 2021-06-30 was $0.00.
- VBI Vaccines Inc/BC debt conversion, converted instrument, amount for the quarter ending 2021-03-31 was $2.00M.
- VBI Vaccines Inc/BC debt conversion, converted instrument, amount for fiscal 2021 was $2.00M.
| Period end | Debt Conversion, Converted Instrument, Amount 3 month | Debt Conversion, Converted Instrument, Amount 6 month | Debt Conversion, Converted Instrument, Amount 9 month | Debt Conversion, Converted Instrument, Amount 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-13 | $0.00 derived: sum of 2 quarters · filed 2023-03-13 | $0.00 derived: sum of 3 quarters · filed 2023-03-13 | $2.00M 10-K · filed 2023-03-13 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $0.00 derived: sum of 2 quarters · filed 2022-11-10 | $2.00M 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $2.00M 10-Q · filed 2022-08-08 | ||
| 2021-03-31 | $2.00M 10-Q · filed 2022-11-10 |